Steven Schnelle discussed proposed drug pricing and transparency legislation, regulatory activity, and litigation at the Fall IDN Summit and Reverse Expo in Phoenix, Arizona, on September 9, 2019. Specific attention was paid to the Prescription Drug Pricing Reduction Act of 2019 (PDPRA), the Safe Importation Action Plan, and ongoing 340B reimbursement litigation.
For more information, please click here.
